Home

Genpharmasec Ltd Quarterly Result

Image

Genpharmasec Ltd

NSE: GENPHARMASEC

Net Profit - Last Quarter

₹ 0.78 Cr.

Last updated on: Feb 23, 2025

Genpharmasec Ltd Quarterly Results Key Highlights

  • The revenue of Genpharmasec Ltd for the Dec '24 is ₹ 9.3 crore as compare to the Sep '24 revenue of ₹ 6.78 crore.
  • This represent the growth of 37.17%a1# The ebitda of Genpharmasec Ltd for the Dec '24 is ₹ 1.55 crore as compare to the Sep '24 ebitda of ₹ 0.87 crore.
  • This represent the growth of 78.16%a1# The net profit of Genpharmasec Ltd for the Dec '24 is ₹ 0.78 crore as compare to the Sep '24 net profit of ₹ 0.7 crore.
  • This represent the growth of 11.43%a1#.

Genpharmasec Ltd Quarterly Results Analysis

Market Price of Genpharmasec Ltd

1M

1Y

3Y

5Y

Monitoring Genpharmasec Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20252.26
20 Feb 20252.16
19 Feb 20252.06
18 Feb 20252.04
17 Feb 20252.13
14 Feb 20252.24
13 Feb 20252.31
12 Feb 20252.27
11 Feb 20252.25
10 Feb 20252.29

Historical Revenue of Genpharmasec Ltd

No data available

* All values are in crore

Historical EBITDA of Genpharmasec Ltd

No data available

* All values are in crore

Historical Net Profit of Genpharmasec Ltd

No data available

* All values are in crore

Genpharmasec Ltd News Hub

Genpharmasec standalone net profit rises 1866.67% in the June 2024 quarter

Net profit of Genpharmasec rose 1866.67% to Rs 0.59 crore in the quarter ended June 2024 as against

Read more

14 Aug 24

Genpharmasec to conduct board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 13 August 2024. Powered

Read more

08 Aug 24

Genpharmasec announces board meeting date

Genpharmasec will hold a meeting of the Board of Directors of the Company on 12 November 2024 Powere

Read more

07 Nov 24

Genpharmasec standalone net profit rises 9900.00% in the September 2024 quarter

Net profit of Genpharmasec rose 9900.00% to Rs 1.00 crore in the quarter ended September 2024 as aga

Read more

13 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Genpharmasec Ltd

What key financial metrics are included in Genpharmasec Ltd's quarterly results?

Key financial metrics in Genpharmasec Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Genpharmasec Ltd announce its quarterly results?

Genpharmasec Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Genpharmasec Ltd's quarterly performance impact its stock price?

Genpharmasec Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Genpharmasec Ltd's quarterly results on dividends?

The impact of Genpharmasec Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Genpharmasec Ltd's quarterly results?

Yes, Genpharmasec Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions